Interaction of matrix metalloproteinases with pulmonary pollutants

European Respiratory Journal

Volumn 39, Issue 4, 2012, Pages 1021-1032

  Dagouassat, M ^a,b   Lanone, S ^a,b,c   Boczkowski, J ^a,b,c,d  

^a INSERM   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

Diesel; Lung and systemic disease; Matrix metalloproteinases; Particulate exposure

Indexed keywords

CADMIUM; CARBON MONOXIDE; DIESEL FUEL; GASOLINE; GELATINASE A; GELATINASE B; HEAVY METAL; INTERSTITIAL COLLAGENASE; LEAD; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; MERCURY; NANOPARTICLE; NICKEL; NITROGEN DIOXIDE; ORGANIC COMPOUND; OZONE; PERSISTENT ORGANIC COMPOUND; SULFUR DIOXIDE; UNCLASSIFIED DRUG; VOLATILE ORGANIC COMPOUND;

AIR POLLUTANT; AIRWAY REMODELING; ARTICLE; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE EXACERBATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; EXHAUST GAS; EXPOSURE; GENE INDUCTION; HUMAN; INTRACELLULAR SIGNALING; LUNG CARCINOGENESIS; MOLECULAR INTERACTION; NONHUMAN; OXIDATIVE STRESS; PARTICULATE MATTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RESPIRATORY TRACT DISEASE; SUBWAY PARTICULATE MATTER; SYSTEMIC DISEASE;

AIR POLLUTANTS; HUMANS; LUNG; LUNG DISEASES; MATRIX METALLOPROTEINASES;

EID: 84860328017     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00195811     Document Type: Article

References (97)

1. Perez-Padilla R, Schilmann A, Riojas-Rodriguez H. Respiratory health effects of indoor air pollution. Int J Tuberc Lung Dis 2008; 14: 1079-1086.
2. Löffek S, Schilling O, Franzke C-W. Biological role of matrix metalloproteinases: a critical balance. Eur Respir J 2011; 38: 191-208.
3. Health effects of outdoor air pollution. Committee of the Environmental and Occupational Health Assembly of the American Thoracic Society. Am J Respir Crit Care Med 1996; 153: 3-50.
4. Logan WP. Mortality in the London fog incident, 1952. Lancet 1953; 1: 336-338.
5. Avol E, Gauderman J, Tan S, et al. Respiratory effects of relocating to areas of differing air pollution levels. Am J Respir Crit Care Med 2001; 164: 2067-2072. (Pubitemid 34020247)
6. Gauderman J, Gilliland F, Vora H, et al. Association between air pollution and lung function growth in southern California children. Results from a second cohort. Am J Respir Crit Care Med 2002; 166: 76-84. (Pubitemid 34693967)
7. MacNee W, Donaldson K. Exacerbations of COPD. Environmental mechanisms. Chest 2000; 117: Suppl. 2, 390S-397S.
8. Peters J, Avol E, Gauderman J, et al. A study of twelve southern California communities with differing levels and types of air pollution. II. Effects on pulmonary function. Am J Respir Crit Care Med 1999; 159: 768-775. (Pubitemid 29137772)
9. Samet J, Dominici F, Curriero F, et al. Fine particulate air pollution and mortality in 20 US cities, 1987-1994. N Engl J Med 2000; 343: 1742-1749. (Pubitemid 32369215)
10. Tager IB, Balmes J, Lurmann F, et al. Chronic exposure to ambient ozone and lung function in young adults. Epidemiology 2005; 16: 751-759. (Pubitemid 41681541)
11. Wegmann M, Fehrenbach A, Heimann S, et al. NO2-induced airway inflammation is associated with progressive airflow limitation and development of emphysema-like lesions in C57BL/6 mice. Exp Toxicol Pathol 2005; 56: 341-350. (Pubitemid 40585795)
12. Snider GL, Hayes JA, Korthy AL, et al. Centrilobular emphysema experimentally induced by cadmium chloride aerosol. Am Rev Respir Dis 1973; 108: 40-48.
13. Nawrot TS, Vos R, Jacobs L, et al. The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation. Thorax 2011; 66: 748-754.
14. Witschger O, Fabriès JF. Particules ultra-fines et santé au travail. 2. Sources et caractérisation de l'exposition [Ultrafine particles and occupational health. 2. Sources and exposure characterisation]. Hygiène et Sécurité au Travail 2005; 199: 37-54.
15. Clapp RW, Jacobs MM, Loechler EL. Environmental and occupational causes of cancer: new evidence 2005-2007. Rev Environ Health 2008; 23: 1-37. (Pubitemid 351644506)
16. Vineis P, Hoek G, Krzyzanowski M, et al. Air pollution and risk of lung cancer in a prospective study in Europe. Int J Cancer 2006; 119: 169-174.
17. Chiu HF, Cheng MH, Tsai SS, et al. Outdoor air pollution and female lung cancer in Taiwan. Inhal Toxicol 2006; 18: 1025-1031.
18. Hoffmann B, Moebus S, Stang A, et al. Residence close to high traffic and prevalence of coronary heart disease. Eur Heart J 2006; 27: 2696-2702. (Pubitemid 44729871)
19. Peters A, von Klot S, Heier M, et al. Exposure to traffic and the onset of myocardial infarction. N Engl J Med 2004; 351: 1721-1730. (Pubitemid 39383207)
20. Shah AP, Pietropaoli AP, Frasier LM, et al. Effect of inhaled carbon ultrafine particles on reactive hyperemia in healthy human subjects. Environ Health Perspect 2008; 116: 375-380. (Pubitemid 351395607)
21. Sun Q, Wang A, Jin X, et al. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA 2005; 294: 3003-3010. (Pubitemid 41817662)
22. Araujo JA, Barajas B, Kleinman M, et al. Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ Res 2008; 102: 589-596. (Pubitemid 351416760)
23. Sun Q, Yue P, Ying Z, et al. Air pollution exposure potentiates hypertension through reactive oxygen species-mediated activation of Rho/ROCK. Arterioscler Thromb Vasc Biol 2008; 28: 1760-1766.
24. Sun Q, Yue P, Deiuliis JA, et al. Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity. Circulation 2009; 119: 538-546.
25. Churg A, Zhou S, Wright JL. Matrix metalloproteinases in COPD. Eur Respir J 2012; 39: 197-209.
26. Vandenbroucke RE, Dejonckheere R, Libert C. A therapeutic role for matrix metalloproteinase inhibitors in lung diseases? Eur Respir J 2011; 38: 1200-1214.
27. Fanjul-Fernandez M, Folgueras AR, Cabrera S, et al. Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta 2010; 1803: 3-19.
28. Rodriguez D, Morrison CJ, Overall CM. Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim Biophys Acta 2010; 1803: 39-54.
29. Tallant C, Marrero A, Gomis-Ruth FX. Matrix metalloproteinases: fold and function of their catalytic domains. Biochim Biophys Acta 2010; 1803: 20-28.
30. Katsouyanni K. Ambient air pollution and health. Br Med Bull 2003; 68: 143-156. (Pubitemid 38248494)
31. Bell ML, Dominici F, Samet JM. A meta-analysis of time-series studies of ozone and mortality with comparison to the national morbidity, mortality, and air pollution study. Epidemiology 2005; 16: 436-445. (Pubitemid 40847827)
32. Koren HS, Devlin RB, Graham DE, et al. Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis 1989; 139: 407-415. (Pubitemid 19057417)
33. Aris RM, Christian D, Hearne PQ, et al. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am Rev Respir Dis 1993; 148: 1363-1372.
34. Thomson E, Kumarathasan P, Goegan P, et al. Differential regulation of the lung endothelin system by urban particulate matter and ozone. Toxicol Sci 2005; 88: 103-113. (Pubitemid 41548752)
35. Vincent R, Bjarnason SG, Adamson IY, et al. Acute pulmonary toxicity of urban particulate matter and ozone. Am J Pathol 1997; 151: 1563-1570. (Pubitemid 27527919)
36. Tyagi SC, Kumar S, Glover G. Induction of tissue inhibitor and matrix metalloproteinase by serum in human heart-derived fibroblast and endomyocardial endothelial cells. J Cell Biochem 1995; 58: 360-371.
37. Tyagi SC, Ratajska A, Weber KT. Myocardial matrix metalloproteinase(s): localization and activation. Mol Cell Biochem 1993; 126: 49-59. (Pubitemid 23360795)
38. Bouthillier L, Vincent R, Goegan P, et al. Acute effects of inhaled urban particles and ozone: lung morphology, macrophage activity, and plasma endothelin-1. Am J Pathol 1998; 153: 1873-1884. (Pubitemid 28550674)
39. Kenyon NJ, van der Vliet A, Schock BC, et al. Susceptibility to ozone-induced acute lung injury in iNOS-deficient mice. Am J Physiol Lung Cell Mol Physiol 2002; 282: L540-L545. (Pubitemid 34654659)
40. Yoon HK, Cho HY, Kleeberger SR. Protective role of matrix metalloproteinase-9 in ozone-induced airway inflammation. Environ Health Perspect 2007; 115: 1557-1563.
41. D'Haese A, Wuyts A, Dillen C, et al. In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse. J Interferon Cytokine Res 2000; 20: 667-674. (Pubitemid 30481720)
42. Mohan R, Chintala SK, Jung JC, et al. Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J Biol Chem 2002; 277: 2065-2072. (Pubitemid 34968789)
43. Triantaphyllopoulos K, Hussain F, Pinart M, et al. A model of chronic inflammation and pulmonary emphysema after multiple ozone exposures in mice. Am J Physiol Lung Cell Mol Physiol 2011; 300: L691-L700.
44. Shapiro S. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 1998; 10: 602-608. (Pubitemid 28477018)
45. O'Brien DW, Morris MI, Ding J, et al. A mechanism of airway injury in an epithelial model of mucociliary clearance. Respir Res 2004; 5: 10.
46. Boethling R, Fenner K, Howard P, et al. Environmental persistence of organic pollutants: guidance for development and review of POP risk profiles. Integr Environ Assess Manag 2009; 5: 539-556.
47. Wong PS, Vogel CF, Kokosinski K, et al. Arylhydrocarbon receptor activation in NCI-H441 cells and C57BL/6 mice: possible mechanisms for lung dysfunction. Am J Respir Cell Mol Biol 2009; 42: 210-217.
48. Ishida M, Mikami S, Kikuchi E, et al. Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer. Carcinogenesis 2010; 31: 287-295.
49. Ding J, He G, Gong W, et al. Effects of nickel on cyclin expression, cell cycle progression and cell proliferation in human pulmonary cells. Cancer Epidemiol Biomarkers Prev 2009; 18: 1720-1729.
50. Kasprzak KS, Sunderman FW Jr, Salnikow K. Nickel carcinogenesis. Mutat Res 2003; 533: 67-97. (Pubitemid 37487861)
51. Xu Z, Ren T, Xiao C, et al. Nickel promotes the invasive potential of human lung cancer cells via TLR4/MyD88 signaling. Toxicology 2011; 285: 25-30.
52. Csak T, Velayudham A, Hritz I, et al. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. Am J Physiol Gastrointest Liver Physiol 2011; 300: G433-G441.
53. Davison AG, Fayers PM, Taylor AJ, et al. Cadmium fume inhalation and emphysema. Lancet 1988; 1: 663-667. (Pubitemid 18083267)
54. Fievez L, Kirschvink N, Zhang WH, et al. Effects of betamethasone on inflammation and emphysema induced by cadmium nebulisation in rats. Eur J Pharmacol 2009; 606: 210-214.
55. Pöschl U. Atmospheric aerosols: composition, transformation, climate and health effects. Angew Chem Int Ed Engl 2005; 44: 7520-7540.
56. Torres-Duque C, Maldonado D, Perez-Padilla R, et al. Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc 2008; 5: 577-590. (Pubitemid 352031530)
57. Sen B, Mahadevan B, DeMarini DM. Transcriptional responses to complex mixtures: a review. Mutat Res 2007; 636: 144-177. (Pubitemid 350123121)
58. Doornaert B, Leblond V, Galiacy S, et al. Negative impact of DEP exposure on human airway epithelial cell adhesion, stiffness, and repair. Am J Physiol Lung Cell Mol Physiol 2003; 284: L119-L132. (Pubitemid 35471265)
59. Amara N, Bachoual R, Desmard M, et al. Diesel exhaust particles induce matrix metalloprotease-1 in human lung epithelial cells via a NADP(H) oxidase/NOX4 redox-dependent mechanism. Am J Physiol Lung Cell Mol Physiol 2007; 293: L170-L181. (Pubitemid 47080725)
60. Li J, Ghio AJ, Cho SH, et al. Diesel exhaust particles activate the matrix-metalloproteinase-1 gene in human bronchial epithelia in a b-arrestin-dependent manner via activation of RAS. Environ Health Perspect 2009; 117: 400-409.
61. Rutter JL, Mitchell TI, Buttice G, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an ETS binding site and augments transcription. Cancer Res 1998; 58: 5321-5325. (Pubitemid 28551108)
62. Zhao M, Wimmer A, Trieu K, et al. Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2. J Biol Chem 2004; 279: 49259-49267. (Pubitemid 39625811)
63. Zhang Q, Kleeberger S, Reddy S. DEP-induced fra-1 expression correlates with a distinct activation of AP1-dependent gene transcription in alveolar epithelial cells. Am J Physiol 2004; 286: L427-L436. (Pubitemid 38129525)
64. Reddy SP, Mossman BT. Role and regulation of activator protein-1 in toxicant-induced responses of the lung. Am J Physiol Lung Cell Mol Physiol 2002; 283: L1161-L1178. (Pubitemid 35379247)
65. Wu L, Tanimoto A, Murata Y, et al. Induction of human matrix metalloproteinase-12 gene transcriptional activity by GM-CSF requires the AP-1 binding site in human U937 monocytic cells. Biochem Biophys Res Commun 2001; 285: 300-307. (Pubitemid 32918070)
66. Tower GB, Coon CI, Belguise K, et al. Fra-1 targets the AP-1 site/2G single nucleotide polymorphism (ETS site) in the MMP-1 promoter. Eur J Biochem 2003; 270: 4216-4225. (Pubitemid 37281640)
67. Matsuzaki T, Amakawa K, Yamaguchi K, et al. Effects of diesel exhaust particles on human neutrophil activation. Exp Lung Res 2006; 32: 427-439. (Pubitemid 44949860)
68. Kusaka Y, Yokoyama K, Sera Y, et al. Respiratory diseases in hard metal workers: an occupational hygiene study in a factory. Br J Ind Med 1986; 43: 474-485. (Pubitemid 16090753)
69. Dick CA, Brown DM, Donaldson K, et al. The role of free radicals in the toxic and inflammatory effects of four different ultrafine particle types. Inhal Toxicol 2003; 15: 39-52. (Pubitemid 36090821)
70. Beaver LM, Stemmy EJ, Schwartz AM, et al. Lung inflammation, injury, and proliferative response after repetitive particulate hexavalent chromium exposure. Environ Health Perspect 2009; 117: 1896-1902.
71. Toxicological Profile for Chromium. Atlanta, Agency for Toxic Substances and Disease Registry, 2000.
72. Fishbein L. Sources, transport and alterations of metal compounds: an overview. I. Arsenic, beryllium, cadmium, chromium, and nickel. Environ Health Perspect 1981; 40: 43-64. (Pubitemid 12231146)
73. Cobos-Correa A, Trojanek JB, Diemer S, et al. Membrane-bound FRET probe visualizes MMP12 activity in pulmonary inflammation. Nat Chem Biol 2009; 5: 628-630.
74. Bigert C, Alderling M, Svartengren M, et al. Blood markers of inflammation and coagulation and exposure to airborne particles in employees in the Stockholm underground. Occup Environ Med 2008; 65: 655-658.
75. Seaton A, Cherrie J, Dennekamp M, et al. The London Underground: dust and hazards to health. Occup Environ Med 2005; 62: 355-362. (Pubitemid 40769189)
76. McClellan RO. Setting ambient air quality standards for particulate matter. Toxicology 2002; 181: 329-347. (Pubitemid 36018739)
77. Ré gie Autonome des Transports Parisiens. www.ratp.fr/fr/ratp/ c-5042/le-reseau/ Date last accessed: November 7, 2011.
78. Bachoual R, Boczkowski J, Goven D, et al. Biological effects of particles from the Paris subway system. Chem Res Toxicol 2007; 20: 1426-1433. (Pubitemid 350057211)
79. Kocbach A, Totlandsdal AI, Lag M, et al. Differential binding of cytokines to environmentally relevant particles: a possible source for misinterpretation of in vitro results? Toxicol Lett 2008; 176: 131-137.
80. Lanone S, Boczkowski J. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Curr Mol Med 2006; 6: 651-663. (Pubitemid 44377764)
81. Wan R,Mo Y, Zhang X, et al. Matrix metalloproteinase-2 and -9 are induced differently by metal nanoparticles in human monocytes: the role of oxidative stress and protein tyrosine kinase activation. Toxicol Appl Pharmacol 2008; 233: 276-285. (Pubitemid 50306576)
82. Zhang Q, Kusaka Y, Sato K, et al. Differences in the extent of inflammation caused by intratracheal exposure to three ultrafine metals: role of free radicals. J Toxicol EnvironHealth A 1998; 53: 423-438.
83. Morimoto Y, Oyabu T, Ogami A, et al. Investigation of gene expression of MMP-2 and TIMP-2 mRNA in rat lung in inhaled nickel oxide and titanium dioxide nanoparticles. Ind Health 2011; 49: 344-352.
84. Merget R, Bauer T, Kupper HU, et al. Health hazards due to the inhalation of amorphous silica. Arch Toxicol 2002; 75: 625-634. (Pubitemid 34151149)
85. Choi M, Cho WS, Han BS, et al. Transient pulmonary fibrogenic effect induced by intratracheal instillation of ultrafine amorphous silica in A/J mice. Toxicol Lett 2008; 182: 97-101.
86. Lund AK, Lucero J, Lucas S, et al. Vehicular emissions induce vascular MMP-9 expression and activity associated with endothelin-1-mediated pathways. Arterioscler Thromb Vasc Biol 2009; 29: 511-517.
87. Campen MJ, Lund AK, Doyle-Eisele ML, et al. A comparison of vascular effects from complex and individual air pollutants indicates a role for monoxide gases and volatile hydrocarbons. Environ Health Perspect 2010; 118: 921-927.
88. Gough PJ, Gomez IG, Wille PT, et al. Macrophage expression of active MMP-9 induces acute plaque disruption in ApoE-deficient mice. J Clin Invest 2006; 116: 59-69. (Pubitemid 43121791)
89. Blankenberg S, Rupprecht HJ, Poirier O, et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 2003; 107: 1579-1585. (Pubitemid 36397324)
90. Ramos C, Cisneros J, Gonzalez-Avila G, et al. Increase of matrix metalloproteinases in woodsmoke-induced lung emphysema in guinea pigs. Inhal Toxicol 2009; 21: 119-132.
91. Wright J, Farmer SG, Churg A. Synthetic serine elastase inhibitor reduces cigarette smoke-induced emphysema in guinea pigs. Am J Respir Crit Care Med 2002; 166: 954-960. (Pubitemid 35193225)
92. Ding M, Kisin ER, Zhao J, et al. Size-dependent effects of tungsten carbide-cobalt particles on oxygen radical production and activation of cell signaling pathways in murine epidermal cells. Toxicol Appl Pharmacol 2009; 241: 260-268.
93. Gorina R, Font-Nieves M, Marquez-Kisinousky L, et al. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NF-kB signaling, MAPK, and Jak1/Stat1 pathways. Glia 2011; 59: 242-255.
94. Li H, Xu H, Liu S. Toll-like receptor 4 induces expression of matrix metalloproteinase-9 in human aortic smooth muscle cells. Mol Biol Rep, 38: 1419-1423.
95. Sacre SM, Andreakos E, Kiriakidis S, et al. The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. Am J Pathol 2007; 170: 518-525. (Pubitemid 47339389)
96. Geraghty P, Dabo AJ, D'Armiento J. TLR4 protein contributes to cigarette smoke-induced matrix metalloproteinase-1 (MMP-1) expression in chronic obstructive pulmonary disease. J Biol Chem 2011; 286: 30211-30218.
97. Kim SY, Lee JG, Cho WS, et al. Role of NADPH oxidase-2 in lipopolysaccharide-induced matrix metalloproteinase expression and cell migration. Immunol Cell Biol 2010; 88: 197-204.